Disseminated visceral Kaposi's sarcoma has emerged as a common complication of the acquired immune deficiency syndrome (AIDS). The diagnosis of Kaposi's sarcoma of the lung by fibreoptic bronchoscopy has proved difficult; open lung biopsy has been advocated as the only satisfactory diagnostic procedure. We report four patients in a series of 11 in whom pulmonary Kaposi's sarcoma was diagnosed by fibreoptic bronchoscopy.
Patients and methods
Thirteen fibreoptic bronchoscopies were performed on 11 men presenting consecutively with pulmonary complications of AIDS. All the patients were homosexual. Endobronchial Kaposi's sarcoma was seen in one patient as diffuse, red, friable streaks throughout the mucosa of the tracheobronchial tree. Three bronchial biopsies were performed, histological examination of the specimens showed Kaposi's sarcoma. In a second patient numerous discrete, purple, red raised lesions with a smooth surface were seen in the trachea and main bronchi. This appearance was identical to that of Kaposi's sarcoma in other mucous membranes and no biopsy samples were taken. The tracheobronchial mucosa in the other nine patients appeared normal and biopsy samples were not taken.
Four to six transbronchial biopsy specimens were taken in all patients from the lobe that was most affected on the chest radiograph. Each biopsy specimen was embedded in paraffin wax, sectioned at five levels, and stained with haematoxylin and eosin, Perl's stain for haemosiderin, and Gordon and Sweet's impregnation stain for reticulin. Pulmonary Kaposi's sarcoma was found by transbronchial biopsy in a further two patients (table) . No evidence of bronchopulmonary Kaposi's sarcoma has been found in the remaining seven patients of whom three have had further bronchoscopies. Three of the seven have died, the longest surviving for 18 months from initial presentation. In the four patients still alive the longest survival has been for 17 months. Necropsies were not performed on any patients.
Discussion
Before the outbreak of AIDS in 1981, Kaposi's sarcoma was a rare neoplasm seen mainly in Ashkenazi Jews in Poland, Italy, and Russia. In the classical form described by Kaposi in 1872 it was a disease of the elderly affecting mainly the skin of the distal limbs. Although it followed an indolent course, up to 30% of patients developed an associated lymphoreticular neoplasm. In areas of east central Africa, the natural history of Kaposi's sarcoma is different. Here it accounts for up to 9% of all malignant tumours and runs an aggressive course among young adults, with widespread disease of lymph nodes and viscera. The reason why Kaposi's sarcoma has proved so elusive at bronchoscopy is uncertain; the explanation may lie partly in the patchy distribution of microscopic foci of neoplasm throughout the lung parenchyma and in the absence of specific tumour markers. Open lung biopsy specimens have shown a predominantly lymphatic distribution in the pleura, septa, and peribronchial region,5 this last area being the most accessible to transbronchial biopsy. The histological features are variable; whereas "classical" Kaposi's sarcoma is readily identifiable, early changes comprising only increased numbers of spindle cells, mesenchymal cells, erythrocytes and haemosiderin deposits may be overlooked (fig 1) . Biopsy specimens should be examined specifically for both opportunistic infections and Kaposi's sarcoma. In the tracheobronchial tree Kaposi's sarcoma has a variable appearance, and apart from those lesions that are clearly Kaposi's sarcoma in a patient already known to have the tumour, biopsy specimens should be taken from all areas of abnormal mucosa.
Figures from the Communicable Disease Surveillance Centre show that patients with AIDS who have Kaposi's sarcoma alone have the most favourable prognosis, with a median survival of 21 months from the time of diagnosis. The median survival of those with Pneumocystis carinii pneumonia is 12 5 months and patients with both Kaposi's sarcoma and pneumocystis pneumonia have the worst prognosis-only 6-6 months.6 Although survival has not been influenced by treatments currently available for Kaposi's sarcoma, the differential diagnosis from opportunistic pneumonia is important in the management of the patient and in determining prognosis. 
